Prostate cancer screening is more individualized than a one size fits all approach. In a New York Times OpEd, Deepak A. Kapoor, MD speaks about improvements in prostate cancer screening technology which benefits all men. With the use of PSA derivatives in conjunction with other markers, doctors are able to get a clearer picture of who does and does not require further testing.
To read the PDF, click here.
